962 studies found for:    "Stomach carcinoma"
Show Display Options
Rank Status Study
1 Active, not recruiting Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer
Conditions: Gastric Cancer;   Stomach Cancer
Intervention: Drug: Cetuximab/ Irinotecan/ Cisplatin
2 Recruiting A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
Conditions: Gastric Cancer;   Stomach Cancer;   Gastrectomy
Intervention: Procedure: Roux-en-Y or Billroth II
3 Not yet recruiting Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer
Conditions: Gastric Tumor;   Early Gastric Cancer
Intervention:
4 Completed Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
Conditions: Esophageal Cancer;   Esophagus Cancer;   Cancer of Stomach;   Stomach Cancer
Interventions: Drug: CPT-11;   Drug: Mitomycin C
5 Completed A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2
Conditions: Stomach Neoplasms;   Cancer of Stomach;   Cancer of the Stomach;   Gastric Cancer;   Gastric Neoplasms
Intervention: Drug: ASLAN001
6 Completed Metastatic Gastric Cancer FFCD 03-07
Conditions: Stomach Cancer;   Neoplasm Metastasis
Interventions: Drug: ECC;   Drug: FOLFIRI
7 Not yet recruiting Labeled PET in Studying Patients With Gastric Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Mixed Adenocarcinoma of the Stomach;   Recurrent Gastric Cancer;   Stage IA Gastric Cancer;   Stage IB Gastric Cancer;   Stage IIA Gastric Cancer;   Stage IIB Gastric Cancer;   Stage IIIA Gastric Cancer;   Stage IIIB Gastric Cancer;   Stage IIIC Gastric Cancer
Interventions: Radiation: copper Cu 64-DOTA-trastuzumab;   Device: positron emission tomography;   Other: laboratory biomarker analysis
8 Completed A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients
Conditions: Adenocarcinoma, Scirrhous,;   Linitis Plastica;   Stomach Neoplasms,;   Stomach Diseases,;   Neoplasms by Site;   Neoplasms
Intervention: Drug: TKI258
9 Unknown  GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
Condition: Gastric Neoplasm
Interventions: Procedure: Surgery: Splenectomy;   Procedure: Surgery: Spleen-preservation
10 Terminated Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
Conditions: Cancer of Stomach;   Gastroesophageal Cancer
Intervention: Drug: Pegamotecan
11 Unknown  Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma
Condition: Gastric Carcinoma
Intervention: Drug: Liposomal paclitaxel and capecitabine
12 Completed A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma
Condition: Stomach Neoplasms
Intervention: Drug: S-1, Docetaxel
13 Recruiting Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm
Condition: Gastric Neoplasms
Intervention: Procedure: second look endoscopy
14 Completed Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer
Conditions: Gastric Cancer;   Stomach Cancer
Interventions: Procedure: Potentially curative surgery;   Drug: Floxuridine (IP);   Procedure: Adjuvant Chemoradiation therapy
15 Unknown  Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
Condition: Stomach Neoplasms
Intervention: Drug: S-1,oxaliplatin
16 Active, not recruiting Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Conditions: Esophageal Cancer;   Gastric Cancer;   Stomach Cancer
Interventions: Drug: Bevacizumab;   Drug: Cisplatin;   Drug: Irinotecan;   Device: Docetaxel
17 Completed Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors
Conditions: Gastric Tumor;   Helicobacter Pylori;   Endoscopic Resection;   Metachronous Neoplasms
Intervention: Drug: eradication treatment of Helicobacter pylori infection
18 Terminated A Phase I/II Study of Genasense (G3139) in Combination With Cisplatin and Fluorouracil in Patients With Advanced Esophageal, Gastro-Esophageal Junction and Gastric Cancer
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Mixed Adenocarcinoma of the Stomach;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Squamous Cell Carcinoma of the Esophagus;   Stage IIIA Esophageal Cancer;   Stage IIIA Gastric Cancer;   Stage IIIB Esophageal Cancer;   Stage IIIB Gastric Cancer;   Stage IIIC Esophageal Cancer;   Stage IIIC Gastric Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer
Interventions: Biological: oblimersen sodium;   Other: laboratory biomarker analysis;   Drug: cisplatin;   Drug: fluorouracil
19 Completed A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer
Conditions: HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma;   HER2 + Breast Cancer;   HER2 + Gastric Cancer;   Squamous Cell Carcinoma of Head and Neck;   Esophageal Squamous Cell Carcinoma
Intervention: Drug: LJM716
20 Completed Randomized Trial of Adjuvant Chemotherapy With Cisplatin Followed by UFT in Serosa-Positive Gastric Cancer (JCOG9206-2)
Condition: Gastric Neoplasm
Interventions: Procedure: Gastrectomy with D2 or greater lymph node dissection;   Drug: Gastrectomy+ chemotherapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years